LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.08 | 27.76 | 653 | 6849 | 0.0953 | 0.4879 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.08 | 27.76 | 3623 | 6849 | 0.5289 | 0.8460 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.78 | 27.76 | 3694 | 6893 | 0.5359 | 0.8492 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.78 | 27.76 | 3716 | 6893 | 0.5391 | 0.8506 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.78 | 27.76 | 643 | 6893 | 0.0933 | 0.4844 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.78 | 27.76 | 3619 | 6893 | 0.5250 | 0.8444 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.48 | 27.76 | 3862 | 6957 | 0.5551 | 0.8576 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.48 | 27.76 | 3884 | 6957 | 0.5582 | 0.8589 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.48 | 27.76 | 760 | 6957 | 0.1092 | 0.5148 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.48 | 27.76 | 3850 | 6957 | 0.5533 | 0.8569 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.19 | 27.76 | 3954 | 7015 | 0.5636 | 0.8614 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.19 | 27.76 | 3982 | 7015 | 0.5676 | 0.8630 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.19 | 27.76 | 722 | 7015 | 0.1029 | 0.5042 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.19 | 27.76 | 3981 | 7015 | 0.5675 | 0.8630 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.89 | 27.76 | 4123 | 7025 | 0.5869 | 0.8709 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.89 | 27.76 | 4144 | 7025 | 0.5899 | 0.8720 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.89 | 27.76 | 820 | 7025 | 0.1167 | 0.5282 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.89 | 27.76 | 4062 | 7025 | 0.5782 | 0.8674 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.60 | 27.76 | 4293 | 7045 | 0.6093 | 0.8797 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.60 | 27.76 | 4314 | 7045 | 0.6123 | 0.8809 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.60 | 27.76 | 884 | 7045 | 0.1255 | 0.5423 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.60 | 27.76 | 4222 | 7045 | 0.5992 | 0.8758 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.31 | 27.76 | 4452 | 6976 | 0.6382 | 0.8905 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.31 | 27.76 | 4469 | 6976 | 0.6406 | 0.8914 | MN20160318_Q01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.31 | 27.76 | 921 | 6976 | 0.1320 | 0.5515 | MN20160318_Q01 | N13 |